Late clinical-stage nanomedicine company NANOBIOTIX has named Professor Robert Langer, Institute Professor at the Massachusetts Institute of Technology (MIT), as Scientific Advisor.
Professor Robert Langer joins Nanobiotix as Scientific Advisor
Late clinical-stage nanomedicine company NANOBIOTIX has named Professor Robert Langer, Institute Professor at the Massachusetts Institute of Technology (MIT), as Scientific Advisor.
Tags
Related posts
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
